Obesity

Weight Management Weight Loss Treatment Options Weight Loss Treatments Health Risks Causes Treatment Childhood Obesity Body Mass Index Medications

Hibernation-Linked DNA Switches Discovered in Human Genome

These conserved regulatory switches offer new avenues for targeted therapies against diabetes, obesity, neurodegeneration

Gut Microbe-Derived Tryptophan Metabolites Restore Hormone-Producing Gut Cells in Obesity

Duke Uncovers 'Neurobiotic Sense' for Instant Gut-Brain Satiety Signals

Colon’s Neurobiotic Sense Detects Bacterial Flagellin to Suppress Appetite

Meta-Analysis Finds Predictable Weight Rebound After Stopping Anti-Obesity Drugs

GLP-1 Weight-Loss Drugs Fail to Boost Fitness and Cause Significant Muscle Loss

Obesity-Linked Cancer Death Rate Triples in U.S., Study at ENDO 2025 Finds

Extracellular Vesicle Transcriptome Study Identifies 282 Obesity-Linked RNAs

Landmark PNAS Study Redirects Obesity Focus to Ultra-Processed Foods

GLP-1 Weight-Loss Drugs Linked to Testosterone Normalization in Men

Hims & Hers Plans Canadian Launch of Generic Semaglutide After Zava Acquisition

Key Treatment and Patient Traits Predict Weight Loss Success With GLP-1 Agonists

Katie Price’s Son Harvey to Begin Mounjaro Treatment Ahead of Southampton Move

Liraglutide Pilot Study Halves Chronic Migraine Days, Paves Way for Randomized Trials

Bioelectrical Impedance Analysis Outperforms BMI in Predicting Long-Term Mortality

WHO Urges Bold Prevention to Curb 1.8 Million Premature Deaths in Europe

Amgen Advances Monthly Obesity Drug to Phase 3 After 20% Weight Loss in Mid-Stage Trial

Susan Anderson Drops 7st13lbs With Slimpod Audio and Mounjaro

Experimental Drug SANA Boosts Fat Thermogenesis to Promote Weight Loss Ahead of Phase 2 Trials

New Oral β2 Agonist Preserves Muscle in Early Weight-Loss Trials